Bluefront Equity
Overview
Bluefront Equity is an Oslo-based private equity firm that specializes in impact investments within the seafood, aquaculture, and climate sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cryogenetics AS | Oct 2024 | Buyout/LBO | Lead |
| AquaBioTech Group | Aug 2021 | Growth Equity | Lead |
| Akvasafe AS | Feb 2022 | Private Equity | Co-investor |
For institutional investors. Book with your work email.
Key People
Kjetil Haga
Founding Partner
Simen Landmark
Founding Partner
Johan Kostveit
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bluefront Equity based?
Bluefront Equity is headquartered in Oslo, Norway.
When was Bluefront Equity founded?
Bluefront Equity was founded in 2020.
How many portfolio companies does Bluefront Equity have?
Bluefront Equity has 8 portfolio companies in Caplight's dataset.
What are some companies in Bluefront Equity's portfolio?
Portfolio companies visible on Caplight include Cryogenetics AS, AquaBioTech Group, Akvasafe AS.
What was Bluefront Equity's most recent investment shown here?
Bluefront Equity's most recent investment in this portfolio sample was in Cryogenetics AS in 2024.
What sectors does Bluefront Equity focus on?
Bluefront Equity focuses on Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Enterprise Software, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Energy & Sustainability, Energy & Sustainability.
What company stages does Bluefront Equity focus on?
Bluefront Equity typically invests at the Late stage.
What is Bluefront Equity's AUM?
Bluefront Equity's assets under management are estimated between $162.0M and $166.0M.